643 related articles for article (PubMed ID: 12394209)
1. Hepatocellular carcinoma: an epidemiologic view.
El-Serag HB
J Clin Gastroenterol; 2002; 35(5 Suppl 2):S72-8. PubMed ID: 12394209
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: recent trends in the United States.
El-Serag HB
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S27-34. PubMed ID: 15508094
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
Tangutur NK; Medvedev SF; Regenstein F; Balart LA
J La State Med Soc; 2011; 163(4):185-90. PubMed ID: 21954650
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology and prevention of hepatocellular carcinoma.
Monto A; Wright TL
Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
[TBL] [Abstract][Full Text] [Related]
5. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
6. Global trends and predictions in hepatocellular carcinoma mortality.
Bertuccio P; Turati F; Carioli G; Rodriguez T; La Vecchia C; Malvezzi M; Negri E
J Hepatol; 2017 Aug; 67(2):302-309. PubMed ID: 28336466
[TBL] [Abstract][Full Text] [Related]
7. Chronic hepatitis B and hepatocellular carcinoma.
McClune AC; Tong MJ
Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
10. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study.
Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
Scand J Gastroenterol; 2019 Aug; 54(8):1027-1032. PubMed ID: 31389730
[No Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma in the Asia pacific region.
Yuen MF; Hou JL; Chutaputti A;
J Gastroenterol Hepatol; 2009 Mar; 24(3):346-53. PubMed ID: 19220670
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
[TBL] [Abstract][Full Text] [Related]
13. [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany].
Erhardt A; Theobald I; Petry W; Röhrborn A; Heintges T; Wettstein M; Häussinger D
Dtsch Med Wochenschr; 2002 Dec; 127(50):2665-8. PubMed ID: 12481236
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.
Walter SR; Thein HH; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Gastroenterol Hepatol; 2011 Dec; 26(12):1757-64. PubMed ID: 21615789
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of hepatocellular carcinoma.
el-Serag HB
Clin Liver Dis; 2001 Feb; 5(1):87-107, vi. PubMed ID: 11218921
[TBL] [Abstract][Full Text] [Related]
17. Environmental factors and risk for hepatocellular carcinoma.
Yu MC; Yuan JM
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S72-8. PubMed ID: 15508106
[TBL] [Abstract][Full Text] [Related]
18. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: the high-risk patient.
Nissen NN; Martin P
J Clin Gastroenterol; 2002; 35(5 Suppl 2):S79-85. PubMed ID: 12394210
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]